Ultrasound contrast agent loaded with nitric oxide as a theranostic microdevice

Drug Design, Development and Therapy

Volumn 9, Issue , 2015, Pages 2409-2419

  Grishenkov, Dmitry ^a,b,c   Gonon, Adrian ^a,c   Weitzberg, Eddie ^a   Lundberg, Jon O ^a   Harmark, Johan ^b   Cerroni, Barbara ^d   Paradossi, Gaio ^d   Janerot Sjoberg, Birgitta ^a,b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Contrast agent; Microbubbles; Myocardial ischemia; Nitric oxide; Ultrasound

Indexed keywords

CONTRAST MEDIUM; NITRIC OXIDE; POLYVINYL ALCOHOL; GAS; POWDER;

ANIMAL CELL; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CYTOTOXICITY TEST; DRY POWDER; ECHOGRAPHY; HEARING TEST; HEART MUSCLE ISCHEMIA; IN VITRO STUDY; MICROBUBBLE; MOUSE; NONHUMAN; PHAGOCYTOSIS; CHEMISTRY; DEVICES; DRUG EFFECTS; GAS; HUMAN; MACROPHAGE; MEDICINAL CHEMISTRY; MYOCARDIAL ISCHEMIA; PARTICLE SIZE; POWDER; PROCEDURES; THERANOSTIC NANOMEDICINE; ULTRASOUND;

CHEMISTRY, PHARMACEUTICAL; CONTRAST MEDIA; EQUIPMENT AND SUPPLIES; GASES; HUMANS; IN VITRO TECHNIQUES; MACROPHAGES; MICROBUBBLES; MYOCARDIAL ISCHEMIA; NITRIC OXIDE; PARTICLE SIZE; PHAGOCYTOSIS; POWDERS; THERANOSTIC NANOMEDICINE; ULTRASONICS;

EID: 84929178166     PISSN: None     EISSN: 11778881     Source Type: Journal    
DOI: 10.2147/DDDT.S77790     Document Type: Article

References (44)

1. Allen TM, Cullis PR. Drug delivery systems: entering the mainstream. Science. 2004;303:1818–1822.
2. Mendis S, Puska P, Norrving B. Global Atlas on Cardiovascular Disease Prevention and Control. Geneva, Switzerland: World Health Organization; 2011.
3. Lindner JR. Microbubbles in medical imaging: current applications and future directions. Nat Rev Drug Discovery. 2004;3:527–533.
4. Cohen J, Cheirif J, Segar D, et al. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent: results of a phase III multicenter trial. J Am Coll Cardiol. 1998;32:746–752.
5. Schneider M. Characteristics of SonoVue. Echocardiography. 1999;16:743–746.
6. Christiansen JP, Lindner JR. Molecular and cellular imaging with targeted contrast ultrasound. Proc IEEE. 2005;93:809–818.
7. Gorce JM, Arditi M, Schneider M. Influence of bubble size distribution on the echogenicity of ultrasound contrast agents: a study of Sonovue. Invest Radiol. 2000;35:661–671.
8. Klibanov AL. Microbubble contrast agent: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications. Invest Radiol. 2006;41:354–362.
9. Leuschner F, Dutta P, Gorbatov R, et al. Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol. 2011;29:1005–1010.
10. Delalande A, Kotopoulis S, Rovers T, Pichon C, Postema M. Sonoporation at a low mechanical index. Bubble Sci Eng Technol. 2011;3:3–12.
11. Darra E, Rungatscher A, Carcereri de Prati A, et al. Dual modulation of nitric oxide production in the heart during ischaemia/reperfusion injury and inflammation. Thromb Haemost. 2010;104:200–206.
12. Gonon AT, Jung C, Katz A, et al. Local arginase inhibition during early reperfusion mediates cardioprotection via increased nitric oxide production. PLoS One. 2012;7:e42038.
13. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1986;327:524–526.
14. Radomski MW, Palmer RMJ, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. 1987;330:1057–1058.
15. Gaboury J, Woodman RC, Granger DN, Reinhardt P, Kubes P. Nitric oxide prevents leukocyte adherence: role of superoxide. Am J Physiol. 1993;265:H862–H862.
16. Luiking Y, Engelen M, Deutz N. Regulation of nitric oxide production in health and disease. Curr Opin Clin Nutr Metab Care. 2010;13:97–104.
17. Bertuglia S. Mechanisms by which low-intensity ultrasound improve tolerance to ischemia-reperfusion injury. Ultrasound Med Biol. 2007;33:663–671.
18. Dörner J, Struck R, Zimmer S, et al. Ultrasound-mediated stimulation of microbubbles after acute myocardial infarction and reperfusion ameliorates left-ventricular remodelling in mice via improvement of borderzone vascularization. PloS One. 2013;8:e56841.
19. Postema M, Bouakaz A, ten Cate FJ, Schmitz G, De Jong N, van Wamel A. Nitric oxide delivery by ultrasonic cracking: some limitations. Ultrasonics. 2006;44:e109–e113.
20. Cavalieri F, El Hamassi A, Chiessi E, Paradossi G. Stable polymeric microballoons as multifunctional device for biomedical uses: synthesis and characterization. Langmuir. 2005;21:8758–8764.
21. Brismar TB, Grishenkov D, Gustafsson B, et al. Magnetite nanoparticles can be coupled with microbubbles to support multimodal imaging. Biomacromolecules. 2012;13:1390–1399.
22. Grishenkov D, Pecorari C, Brismar TB, Paradossi G. Characterization of acoustic properties of PVA-shelled ultrasound contrast agents: linear properties (Part I). Ultrasound Med Biol. 2009;35:1127–1138.
23. Pecorari C, Grishenkov D. Characterization of ultrasound-induced fracture of polymer-shelled ultrasonic contrast agents by correlation analysis. J Acoust Soc Am. 2007;122:2425–2430.
24. Govoni M, Jansson EA, Weitzberg E, Lundberg JO. The increase in plasma nitrite after a dietary nitrate load is markedly attenuated by an antibacterial mouthwash. Nitric Oxide. 2008;19:333–337.
25. Tortora G, Grabowski SR. Introduction to the Human Body. New York, USA: John Willey & Sons, Inc.; 2001.
26. Baluk P, Hirata A, Thurston G, et al. Endothelial gaps: time course of formation and closure in inflamed venules of rats. Am J Physiol. 1997;272:L155–L170.
27. Paradossi G, Pellegretti P, Trucco A. Ultrasound Contrast Agents. Targeting and Processing Methods for Theranostics. Milan, Italy: Springer-Verlag; 2010:25–39.
28. Zheng M. Ultrasound contrast agents: fabrication, size distribution and visualization. KTH DiVA. 2011.
29. De Jong N, Cornet R, Lancee CT. Higher harmonics of vibrating gas-filled microspheres. Part one: simulations. Ultrasonics. 1994;32:447–453.
30. Cavalieri F, Finelli I, Tortora M, et al. Polymer microbubbles as diagnostic and therapeutic gas delivery device. Chem Mater. 2008;20:3254–3258.
31. Poehlmann M, Grishenkov D, Kothapalli SVVN, et al. On the interplay of shell structure with low and high-frequency mechanics of multifunctional magnetic microbubbles. Soft Matter. 2014;10:214–226.
32. Harrisson F, Callebaut M, Vakaet L. Microspectrographic analysis of Trypan Blue-induced fluorescence in oocytes of the Japanese quail. Histochemistry. 1981;72:563–578.
33. Paradossi G, Pellegretti P, Trucco A. Ultrasound contrast agents. Targeting and processing methods for theranostics. Milan, Italy: Springer-Verlag; 2010:67–77.
34. Barrefelt A, Saghafian M, Kuiper R, et al. Biodistribution, kinetics, and biological fate of SPION microbubbles in the rat. Int J Nanomedicine. 2013;8:3241–3254.
35. El-Sherif D, Wheatley MA. Development of a novel method for synthesis of a polymeric ultrasound contrast agent. J Biomed Mat Res A. 2003;66:347–355.
36. Grishenkov D, Gonon A, Paradossi G, Janerot-sjoberg B. Ultrasound contrast agent loaded with nitric oxide as a theranostic microdevice for myocardial ischemia. Proceedings of the Medicinteknikdagarna Conference; Oct 1–2, 2013, Stockholm, Sweden. Malmokongressbyra; 2013.
37. Morse PM, Ingard KU. Theoretical Acoustics. New York, USA: McGraw Hill; 1968.
38. Church C. The effect of an elastic solid surface layer on the radial pulsations of gas bubbles. J Acoust Soc Am. 1995;97:1510–1521.
39. Kothapalli SVVN, Oddo L, Paradossi G, et al. Assessment of the viscoelastic and oscillation properties of a nanoengineered, shelled multi-modality contrast agent. Ultrasound Med Biol. 2014;40:2476–2487.
40. Hoff L. Acoustic Characterization of Contrast Agents for Medical Ultrasound Imaging. Dordrecht, the Netherlands: Springer; 2001: 105–120.
41. Bamber JC, Hill CR. Ultrasonic attenuation and propagation speed in mammalian tissues as a function of temperature. Ultrasound Med Biol. 1979;5:149–157.
42. Marmottant P, van der Meer S, Emmer M, et al. A model for large amplitude oscillations of coated bubbles accounting for buckling and rupture. J Acoust Soc Am. 2005;118:3499–3505.
43. Wei K, Jayaweera AR, Firoozan S, et al. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation. 1998;97:473–483.
44. Sciallero C, Paradossi G, Trucco A. A preliminary in vitro assessment of polymer-shelled microbubbles in contrast-enhanced ultrasound imaging. Ultrasonics. 2012;52:456–464.